Zhejiang Xinguang Pharmaceutical Co., Ltd.

Total Valuation

Zhejiang Xinguang Pharmaceutical Co., Ltd. carries a market capitalization of 1.99B, placing it among publicly traded companies globally. Its enterprise value stands at 1.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Zhejiang Xinguang Pharmaceutical Co., Ltd. currently has 160.00M shares outstanding.

Valuation Ratios

Zhejiang Xinguang Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 42.75. The price-to-sales ratio is 9.25, and the price-to-book ratio stands at 4.56.

Enterprise Valuation

On an enterprise value basis, Zhejiang Xinguang Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 49.44 and an EV/FCF ratio of 416.97. The EV/Sales ratio of 6.68 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 49.44 provides insight into valuation relative to core operating earnings.

Financial Position

Zhejiang Xinguang Pharmaceutical Co., Ltd. maintains a current ratio of 13.09, meaning it holds 13.1x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Zhejiang Xinguang Pharmaceutical Co., Ltd. posts a return on equity of 10.69 and a return on invested capital of 3.84.

Taxes

Over the trailing twelve months, Zhejiang Xinguang Pharmaceutical Co., Ltd. has paid 7.82M in income taxes, reflecting an effective tax rate of 12.11.

Stock Price Statistics

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s stock has declined approximately -18.0317% over the past 52 weeks. The 50-day moving average sits at 14.30, while the 200-day moving average is 15.49.

Income Statement

Over the trailing twelve months, Zhejiang Xinguang Pharmaceutical Co., Ltd. generated 262.39M in revenue and converted that into 56.79M in net income, yielding earnings per share of 0.35. EBITDA reached 35.43M, while operating income came in at 35.43M.

Balance Sheet

Total book value stands at 532.92M, with working capital of 693.30M providing operational flexibility.

Cash Flow

After subtracting -4.20M in capital expenditures, free cash flow totaled -4.20M - equivalent to -0.03 per share.

Margins

Zhejiang Xinguang Pharmaceutical Co., Ltd. operates with a gross margin of 35.22, reflecting its pricing power and cost economics. The operating margin of 13.50 and net profit margin of 21.64 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s most recent stock split took place on July 4, 2017 with a 1:2 split ratio.

Scores

Zhejiang Xinguang Pharmaceutical Co., Ltd. posts an Altman Z-Score of 24.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.